Mr. Speaker, we are looking at all aspects of our drug approval process. We are looking at the time it takes. We are comparing those approval times with other countries' standards. We are working with the private sector, including drug companies.
We take this very seriously, which is why in fact this was an important commitment made in the Speech from the Throne.